Previously, it was reported that GSCs isolated from GBM biopsies and human glioma cell lines express cannabinoid receptors, in particular, CB2, and other ECS elements, including the enzymes responsible for endocannabinoid degradation, MAGL and FAAH [54]. The gene discussed is CNR2; the disease is central nervous system cancer.